Home
About
Overview
Sharing Data
ORCID
Help
History (2)
A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.
Calcium channel blocker and Rho-associated kinase activity in patients with hypertension.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Calcium channel blocker and Rho-associated kinase activity in patients with hypertension.
Calcium channel blocker and Rho-associated kinase activity in patients with hypertension. J Hypertens. 2011 Feb; 29(2):373-9.
View in:
PubMed
subject areas
Adult
Aged
Amlodipine
Angiotensin II Type 1 Receptor Blockers
Antihypertensive Agents
Calcium Channel Blockers
Case-Control Studies
Cross-Sectional Studies
Double-Blind Method
Female
Humans
Hypertension
Leukocytes
Losartan
Male
Middle Aged
rho-Associated Kinases
authors with profiles
James Liao